Riskpilot← Back to searchSign inGet full accessUppvidinge Tandvård AB
ABActiveOrg 5591604649Järnvägsgatan 33Dental practice care activities · NACE 8623Est. 20182 employees
Revenue 2025
SEK 4,1M
-31% vs 2024
EBITDA margin
40.8%
-46% vs 2024
Equity ratio
74.6%
Financial strength
Net profit 2025
SEK 1,3M
-29% vs 2024
| Revenue | SEK 4,1M | -31% |
| EBITDA | SEK 1,7M | -46% |
| Net profit | SEK 1,3M | -29% |
| Total assets | SEK 13,9M | +5% |
| Equity | SEK 10,4M | +8% |
| Employees | 2 | — |
Legal name
Uppvidinge Tandvård AB
Org number
5591604649
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
29 maj 2018
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandvård samt därmed förenlig verksamhet.
Address
Järnvägsgatan 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 284 | 4 595 | 5 275 | 5 858 | 4 052 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 642 | 1 913 | 2 759 | 3 058 | 1 654 |
| Depreciation & amort. | −172 | −143 | −178 | −141 | −138 |
| EBIT | 2 470 | 1 770 | 2 581 | 2 917 | 1 516 |
| Net financials | −1 | 6 | 198 | 246 | 298 |
| Profit before tax | 2 440 | 2 689 | 2 514 | 2 363 | 1 692 |
| Tax | −517 | −570 | −532 | −501 | −366 |
| Net profit | 1 923 | 2 119 | 1 982 | 1 862 | 1 326 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 091 | 10 200 | 11 689 | 13 236 | 13 890 |
| Equity | 5 525 | 6 950 | 8 332 | 9 614 | 10 365 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 767 | 1 363 | 1 205 | 670 | 451 |
| Total debt | 767 | 1 363 | 1 205 | 670 | 451 |
EBITDA margin
40.8%
This company
15.8%
Market median
+158% vs market
20212025
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
12.8%
This company
18.4%
Market median
+30% vs market
20212025
Net profit margin
32.7%
This company
8.1%
Market median
+304% vs market
20212025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH | Audit | 2022 |
| Former (1) | ||
TA | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Uppvidinge Tandvård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Håkan Urban Davidsson | Audit | 0 companies |
| Tord Arne Ragnar Olsson | Audit | 0 companies |
| Ghiuler Vuap | Deputy Board Member | 0 companies |
| Sibel Ghiulsen Vuap | Board of Directors | 0 companies |